These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 19421006)

  • 1. Molecular chaperones antagonize proteotoxicity by differentially modulating protein aggregation pathways.
    Douglas PM; Summers DW; Cyr DM
    Prion; 2009; 3(2):51-8. PubMed ID: 19421006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid in neurodegenerative diseases: friend or foe?
    Wolfe KJ; Cyr DM
    Semin Cell Dev Biol; 2011 Jul; 22(5):476-81. PubMed ID: 21458579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB; Sherman MY
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular chaperones and neuronal proteostasis.
    Smith HL; Li W; Cheetham ME
    Semin Cell Dev Biol; 2015 Apr; 40():142-52. PubMed ID: 25770416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
    Muchowski PJ
    Neuron; 2002 Jul; 35(1):9-12. PubMed ID: 12123602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases.
    Luo GR; Le WD
    Curr Pharm Biotechnol; 2010 Feb; 11(2):180-7. PubMed ID: 20166963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bistability explains threshold phenomena in protein aggregation both in vitro and in vivo.
    Rieger TR; Morimoto RI; Hatzimanikatis V
    Biophys J; 2006 Feb; 90(3):886-95. PubMed ID: 16299080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of neurodegeneration by molecular chaperones.
    Muchowski PJ; Wacker JL
    Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Chaperones in Neurodegenerative Diseases: A Short Review.
    Bobori C; Theocharopoulou G; Vlamos P
    Adv Exp Med Biol; 2017; 987():219-231. PubMed ID: 28971461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases.
    Ries HM; Nussbaum-Krammer C
    Essays Biochem; 2016 Oct; 60(2):181-190. PubMed ID: 27744334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly.
    Hervás R; Oroz J
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranslational quality control: folding, refolding, and degrading proteins.
    Wickner S; Maurizi MR; Gottesman S
    Science; 1999 Dec; 286(5446):1888-93. PubMed ID: 10583944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases.
    Arawaka S; Machiya Y; Kato T
    Curr Pharm Biotechnol; 2010 Feb; 11(2):158-66. PubMed ID: 20170473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between protein homeostasis networks in protein aggregation and proteotoxicity.
    Douglas PM; Cyr DM
    Biopolymers; 2010 Mar; 93(3):229-36. PubMed ID: 19768782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular chaperones are nanomachines that catalytically unfold misfolded and alternatively folded proteins.
    Mattoo RU; Goloubinoff P
    Cell Mol Life Sci; 2014 Sep; 71(17):3311-25. PubMed ID: 24760129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular chaperones biochemistry and role in neurodegenerative diseases.
    Chaari A
    Int J Biol Macromol; 2019 Jun; 131():396-411. PubMed ID: 30853582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways.
    Koszła O; Sołek P
    Cell Commun Signal; 2024 Aug; 22(1):421. PubMed ID: 39215343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular strategies to cope with protein aggregation.
    Scior A; Juenemann K; Kirstein J
    Essays Biochem; 2016 Oct; 60(2):153-161. PubMed ID: 27744331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chaperones and proteases: cellular fold-controlling factors of proteins in neurodegenerative diseases and aging.
    Hinault MP; Ben-Zvi A; Goloubinoff P
    J Mol Neurosci; 2006; 30(3):249-65. PubMed ID: 17401151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the Critical Activation of Chaperone Machinery in Protein Folding.
    Theocharopoulou G; Vlamos P
    Adv Exp Med Biol; 2020; 1194():351-358. PubMed ID: 32468551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.